Robin Rogiers

Articles

Regulatory Considerations Surrounding Human Challenge Studies with the SARS-CoV-2 Virus

July 24, 2020

A first vaccine against this coronavirus could still take some time to develop, but mRNA vaccine platforms could offer an early breakthrough.